Skip to content

Feasibility and Safety of Human Bone Marrow-derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa

Source: ClinicalTrials.gov – Retinitis Pigmentosa – Feasibility and Safety of Human Bone Marrow-derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa


Condition:   Retinitis Pigmentosa
Intervention:   Other: BM-MSC
Sponsors:   Mahidol University;   Ministry of Health, Thailand
Enrolling by invitation – verified August 2017


Source: ClinicalTrials.gov – Retinitis Pigmentosa – Feasibility and Safety of Human Bone Marrow-derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa

Email this to someoneTweet about this on TwitterShare on FacebookShare on Google+Pin on Pinterest
Published inReports & Studies

Be First to Comment

Leave a Reply